Now PlayingEP. 1 Patient vs Provider Perceptions: Expert Opinions on Addressing the Emotional Impact of Vitiligo
EP. 2 Vitiligo in a 35-Year-Old Female: Case-Based Discussion, Treatment Sequencing, and Practical Insights
EP. 3 Vitiligo Case-Based Discussion: Impact of Stigma, Social Perception, and Practical Management Strategies
EP. 4 Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American Patients
Study Identifies Metabolic Pathway Linking Hyperglycemia to Vitiligo ProgressionByShannon Heaning, Content AssociateJuly 14th 2026
Roundtable Discussion Weighs Access and Adherence Challenges in Vitiligo Care ByKaitlyn Bader, Assistant Managing EditorJuly 13th 2026
Phase 1b Trial of FB102 Demonstrates Significant Facial Repigmentation and Sustained Vitiligo ResponseByMarie Bosslett, Assistant EditorJuly 9th 2026
First Patient Dosed in Phase 2 Trial of Topical Pan-JAK Inhibitor LNK01004 for VitiligoByShannon Heaning, Content AssociateJuly 9th 2026